Abstract

The role traditionally assigned to astrocytes in the pathogenesis of multiple sclerosis (MS) lesions has been the formation of the glial scar once inflammation has subsided. Astrocytes are now recognized to be early and highly active players during lesion formation and key for providing peripheral immune cells access to the central nervous system. Here, we review the role of astrocytes in the formation and evolution of MS lesions, including the recently described functional polarization of astrocytes, discuss prototypical pathways for astrocyte activation, and summarize mechanisms by which MS treatments affect astrocyte function.

Highlights

  • The Role of Astrocytes in Multiple SclerosisThe role traditionally assigned to astrocytes in the pathogenesis of multiple sclerosis (MS) lesions has been the formation of the glial scar once inflammation has subsided

  • Multiple sclerosis (MS) is an autoimmune disease that targets the central nervous system (CNS) [1]

  • Astrocytes make up approximately 30% of glial cells in the CNS, where each astrocyte occupies a unique territory demarcated by non-overlapping, star-shaped processes that extend from the cell soma [25, 26]

Read more

Summary

The Role of Astrocytes in Multiple Sclerosis

The role traditionally assigned to astrocytes in the pathogenesis of multiple sclerosis (MS) lesions has been the formation of the glial scar once inflammation has subsided. Astrocytes are recognized to be early and highly active players during lesion formation and key for providing peripheral immune cells access to the central nervous system. We review the role of astrocytes in the formation and evolution of MS lesions, including the recently described functional polarization of astrocytes, discuss prototypical pathways for astrocyte activation, and summarize mechanisms by which MS treatments affect astrocyte function. Reviewed by: Chiara Cordiglieri, Istituto Nazionale Genetica Molecolare (INGM), Italy. Specialty section: This article was submitted to Multiple Sclerosis and Neuroimmunology, a section of the journal Frontiers in Immunology

INTRODUCTION
THE PHYSIOLOGICAL ROLE OF ASTROCYTES AND ASTROCYTE RESPONSES
THE REACTIVE ASTROCYTE IN MS LESION PATHOLOGY
SIGNALING PATHWAYS IN ASTROCYTES
DIRECT MODULATION OF REACTIVE ASTROCYTE ACTIVITY BY MS TREATMENTS
Dimethyl Fumarate
Fingolimod and Siponimod
Findings
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call